Past, present, and future prospects of medication-overuse headache classification

Headache

Volumn 48, Issue 7, 2008, Pages 1096-1102

  Ferrari, Anna ^a   Coccia, Ciro ^a   Sternieri, Emilio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Analgesic; Chronic daily headache; Classification; Combination; Medication overuse headache; Migraine

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID; BENZODIAZEPINE; BUTALBITAL; CAFFEINE; ERGOTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ANALGESIC AGENT ABUSE; CHRONIC DAILY HEADACHE; DETOXIFICATION; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; HEADACHE; HUMAN; MIGRAINE; OPIATE ADDICTION; PRIORITY JOURNAL; RELAPSE; REVIEW;

ANALGESICS; FORECASTING; HEADACHE DISORDERS, SECONDARY; HUMANS; PROGNOSIS;

EID: 46749132316     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.00919.x     Document Type: Review

References (69)

1. Berg AT, Blackstone NW. Concepts in classification and their relevance to epilepsy. Epilepsy Res. 2006 70 (Suppl 1 S11 S19.
2. Silberstein SD, Olesen J, Bousser MG, et al. On behalf of the International Society. The international classification of headache disorders, 2nd Edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005 25 : 460 465.
3. : Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988 8 (Suppl 7 S9 S96.
5. Rapoport AM. Analgesic rebound headache. Headache. 1988 28 : 662 665.
6. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996 36 : 14 19.
7. Obermann M, Bartsch T, Katsarava Z. Medication overuse headache. Expert Opin Drug Saf. 2006 5 : 49 56.
8. Gladstone JP, Dodick DW. From hemicrania lunaris to hemicrania continua: An overview of the revised international classification of headache disorders. Headache. 2004 44 : 692 705.
9. Ramadan NM, Olesen J. Classification of headache disorders. Semin Neurol. 2006 26 : 157 162.
10. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache-comparison to criteria for chronic tension-type headache. Cephalalgia. 1992 12 : 365 368.
11. Diener HC. A personal view of the classification and definition of drug dependence headache. Cephalalgia. 1993 13 (Suppl 12 S68 S71.
12. Pfaffenrath V, Isler H, Ekbom K. Chronic daily headache: Classification. Cephalalgia. 1993 13 (Suppl 12 S66 S67.
13. Sandrini G, Manzoni GC, Zanferrari C, Nappi G. An epidemiological approach to the nosography of chronic daily headache. Cephalalgia. 1993 13 (Suppl 12 S72 S77.
14. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria. Headache. 1994 34 : 1 7.
15. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996 47 : 871 875.
16. Nappi G, Granella F, Mandrini G, Manzoni GC. Chronic daily headache. How should it be included in the HIS classification? Headache. 1999 39 : 197 203.
17. Manzoni G, Torelli P. International Headache Society classification: New proposals about chronic headache. Neurol Sci. 2003 24 (Suppl 2 S86 S89.
18. Nash JM, Lipchik GL, Holroyd KA, McCool H, Stensland M. American headache society. American headache society members'assessment of headache diagnostic criteria. Headache. 2003 43 : 2 13.
19. Couch JR. Rebound-withdrawal headache (medication overuse headache). Curr Treat Options Neurol. 2006 8 : 11 19.
20. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: Overview and systematic review of therapeutic approaches. Ann Pharmacother. 1999 33 : 61 72.
21. Headache Classification Subcommittee of the International Headache Society. The International Classification Of Headache Disorders, 2nd edition. Cephalalgia. 2004 24 (Suppl 1 S9 S160.
22. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002 59 : 1011 1014.
23. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: The effect of a 2-month drug-free period. Neurology. 2006 66 : 1894 1898.
24. Relja G, Granato A, Bratina A, Antonello RM, Zorzon M. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia. 2006 26 : 589 595.
25. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987 27 : 102 106.
26. Baumgartner C, Wessely P, Bingo L, Maly J, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache. 1989 29 : 510 514.
27. Mathew NT, Kurman R, Perez F. Drug induced refractory headache-clinical features and management. Headache. 1990 30 : 634 638.
28. Silberstein SD, Silberstein JR. Chronic daily headache: Long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992 32 : 439 445.
29. Mathew NT. Transformed migraine. Cephalalgia. 1993 13 (Suppl 12 S78 S83.
30. Schnider P, Baumgartner C, Marterer A, Wober C, Zeiler K, Wessely P. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia. 1996 16 : 481 485.
31. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: Long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001 45 : 229 235.
32. Cady RK, Schreiber CP, Farmer KU. Understanding the patient with migraine: The evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache. Headache. 2004 44 : 426 435.
33. Katsarava Z, Muessing M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005 25 : 12 15.
34. Ferrari A, Leone S, Vergoni AV, et al. Similarities and differences between chronic migraine and episodic migraine. Headache. 2007 47 : 65 72.
35. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: Clinical implications. Headache. 2006 46 (Suppl 4 S202 S211.
36. Mathew NT. The prophylactic treatment of chronic daily headache. Headache. 2006 46 : 1522 1564.
37. Markley HG. Chronic headache: Appropriate use of opiate analgesics. Neurology. 1994 44 (Suppl 3 S18 S24.
38. Wenzel RG, Sarvis CA. Do butalbital containing products have a role in the management of migraine? Pharmacotherapy. 2002 22 : 1029 1035.
39. Silberstein SD, McCrory DC. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001 41 : 953 967.
40. Young WB, Siow HC. Should butalbital-containing analgesics be banned? Yes. Curr Pain Headache Rep. 2002 6 : 151 155.
41. Solomon S. Butalbital-containing agents: Should they be banned? No. Curr Pain Headache Rep. 2002 6 : 147 150.
42. Feinstein AR, Heinemann LAJ, Dalessio D, et al. Do caffeine-containing analgesic promote dependence? A review and evaluation. Clin Pharmacol Ther. 2000 68 : 457 467.
43. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005 119 : 49 55.
44. Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a bioehavioral disorder. Cephalalgia. 2005 25 : 545.
45. Ferrari A, Cicero AFG, Bertolini A, Leone S, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: A comparison between headache patients and addicts by the Leeds dependence questionnaire (LDQ). Cephalalgia. 2006 26 : 187 193.
46. Peres MFP, Mercante JPP, Guendler VZ, et al. Cephalalgiaphobia: A possible specific phobia of illness. J Headache Pain. 2007 8 : 56 59.
47. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: Long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999 19 : 44 49.
48. Smith TR, Stoneman J. Medication overuse headache from antimigraine therapy. Drugs. 2004 64 : 2503 2514.
49. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: Long-term results of withdrawal therapy. J Neurol. 1989 236 : 9 14.
50. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headaches associated with chronic use of analgesics: A therapeutic approach. Headache. 1996 36 : 433 439.
51. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol. 1999 246 : 802 809.
52. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003 23 : 963 971.
53. Bigal ME, Rapaport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 24 : 483 490.
54. ICD-10 Guide for Headaches. Cephalalgia. 1997 19 (Suppl 17 S1 S5.
55. Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: A review. Curr Pain Headache Rep. 2003 7 : 55 62.
56. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC. Risk of ischemic complications related to the intensity of trip-tan and ergotamine use. Neurology. 2006 67 : 1128 1134.
57. Montagna P, Cevoli S, Marzocchi N, et al. The genetics of chronic headaches. Neurol Sci. 2003 24 (Suppl 2 S51 S56.
58. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005 18 : 305 310.
59. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain. 2005 9 : 285 291.
60. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005 25 : 519 522.
61. Horowski R, Ziegler A. Possible pharmacological mechanisms of chronic abuse of analgesics and other antimigraine drugs. In : Diener HC, Wilkinson M, eds. Drug-Induced Headache. Berlin, Heidelberg : Springer-Verlag 1988 5 : 95 104.
62. Silberstein SD, Young WB. Analgesic rebound headache. How great is the problem and what can be done. Drug Safety. 1995 13 : 133 144.
63. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 106 : 81 89.
64. Levin M. Chronic daily headache and the revised International Headache Society classification. Curr Pain Headache Rep. 2004 8 : 59 65.
65. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: Correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache. 2004 44 : 684 691.
66. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Field testing alternative criteria for chronic migraine. Cephalalgia. 2006 26 : 477 482.
67. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia. 2006 26 : 1192 1198.
68. Manzoni GC, Lambru G, Torelli P. Chronically evolving headaches: Classification and terminology. Neurol Sci. 2006 27 (Suppl 2 S164 S167.
69. Bigal M, Rapoport A, Sheftell F, Tepper S, Lip-ton R. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia. 2007 27 : 235 243.